12-Jun-2026
No headlines found.
Materialise to Hold Annual Shareholders' Meeting on June 16, 2026
Globe Newswire (Fri, 15-May 4:01 PM ET)
Materialise Reports First Quarter 2026 Results
Business Wire (Thu, 7-May 1:00 AM ET)
Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026
Business Wire (Thu, 23-Apr 1:00 AM ET)
Materialise to Transfer RapidFit Business to Its Management Team
Globe Newswire (Tue, 31-Mar 2:30 AM ET)
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
Materialise Nv - American Depositary Shares trades on the NASDAQ stock market under the symbol MTLS.
As of June 12, 2026, MTLS stock price climbed to $6.66 with 101,291 million shares trading.
MTLS has a beta of 1.18, meaning it tends to be more sensitive to market movements. MTLS has a correlation of 0.19 to the broad based SPY ETF.
MTLS has a market cap of $387.48 million. This is considered a Small Cap stock.
Last quarter Materialise Nv - American Depositary Shares reported $76 million in Revenue and $.04 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.03.
In the last 3 years, MTLS traded as high as $9.69 and as low as $3.93.
The top ETF exchange traded funds that MTLS belongs to (by Net Assets): PRNT, APIE, GWX, BULD, SPDW.
MTLS has underperformed the market in the last year with a return of +19.6%, while SPY returned +24.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MTLS shares. However, MTLS has outperformed the market in the last 3 month and 2 week periods, returning +22.9% and -0.1%, while SPY returned +11.6% and -1.9%, respectively. This indicates MTLS has been having a stronger performance recently.
MTLS support price is $6.46 and resistance is $6.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTLS shares will trade within this expected range on the day.